These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5172069)

  • 1. [The effect of carbochromen in oral therapy and prevention of experimental cardiac infarction].
    Kipshidze NN; Kikawa GM
    Arzneimittelforschung; 1971 Nov; 21(11):1623-8. PubMed ID: 5172069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic and prophylactic effectiveness of carbochromen in experimental myocardial infarct].
    Kipshidze NN; Kikawa GM
    Acta Cardiol; 1974; 29(3):185-202. PubMed ID: 4135425
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of carbochromen on myocardial blood flow and metabolic heat production before and after acute coronary ligation.
    Grayson J; Irvine M; Parratt JR
    Br J Pharmacol; 1969 Oct; 37(2):523P-524P. PubMed ID: 5348445
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of a coronary vasodilator drug (carbochromen) on blood flow and oxygen extraction in acute myocardial infarction.
    Parratt JR; Ledingham IM; McArdle CS
    Cardiovasc Res; 1973 May; 7(3):401-7. PubMed ID: 4722935
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries.
    Sano N; Sato S; Hashimoto K
    Jpn J Pharmacol; 1972 Dec; 22(6):857-65. PubMed ID: 4541491
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trial of the Cardiocap R capsule with prolonged action in myocardial infarct and coronary insufficiency].
    Sarnari V; Garassini G
    Minerva Cardioangiol; 1973 Nov; 21(11):732-7. PubMed ID: 4776568
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selective vasodilatation of the subepicardial coronary vasculature induced by carbochromen (author's transl)].
    L'Abbate A; Trivella MG; Camici P; Pelosi G; Levantesi D; Taddei L; Marzilli M
    G Ital Cardiol; 1981; 11(5):663-70. PubMed ID: 7286535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies on 1-phenyl-2-1-phenylpropyl-3-amino proprane hydrochloride in dogs with experimental myocardial infarct].
    Manolov P; Chakurov S; Krustev D; Dikov N; Naumov G
    Eksp Med Morfol; 1973; 12(1):18-22. PubMed ID: 4772026
    [No Abstract]   [Full Text] [Related]  

  • 9. Peculiarities of microciirculation and reparative processes in the development of experimental myocardiail infarction.
    Trubetskoy AV; Lysenko LT; Zhdanov VS
    Biochem Exp Biol; 1977; 13(3):283-9. PubMed ID: 16296010
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ischemic myocardial lesions following permanent and temporary coronary artery ligation and subsequent complete cardiac relief by total cardio-pulmonary bypass].
    Krug A; Druschel G; Buchheit H; Bernhard A
    Verh Dtsch Ges Kreislaufforsch; 1971; 37():320-6. PubMed ID: 5140999
    [No Abstract]   [Full Text] [Related]  

  • 11. A minimally invasive model of myocardial infarction made by video-assisted thoracoscopic surgery.
    Zhou XH; Li LD; Wu LM; Wang W; Han L; Yang J; Qiao HX; Zhou XF
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):283-90. PubMed ID: 17609742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of diastolic augmentation on infarct size following coronary artery ligation.
    Nachlas MM; Siedband MP
    J Thorac Cardiovasc Surg; 1967 May; 53(5):698-706. PubMed ID: 6025813
    [No Abstract]   [Full Text] [Related]  

  • 13. The MRL mouse repairs both cryogenic and ischemic myocardial infarcts with scar.
    Grisel P; Meinhardt A; Lehr HA; Kappenberger L; Barrandon Y; Vassalli G
    Cardiovasc Pathol; 2008; 17(1):14-22. PubMed ID: 18160056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems in the experimental study of heart revascularization with the left circumflex coronary artery ligation as a control].
    Kishi K; Hiratsuka H; Akimoto T; Yokoyama M; Ishii N
    Kyobu Geka; 1969 Mar; 22(3):189-94. PubMed ID: 5814295
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic efficacy of carbochromene in experimental myocardial infarct].
    Kipshidze NN; Kikawa GM
    Rev Med Liege; 1973 Apr; 28(7):228-35. PubMed ID: 4730438
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the pharmacodynamic influencing of the coronary blood flow].
    Baubkus H; Dietze G; Müller-Seydlitz P; Zeitlmann F; Gadomski M; Rudolph W
    Verh Dtsch Ges Inn Med; 1969; 75():416-9. PubMed ID: 5400167
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of coronary-active substances on the pathological stress electrocardiogram in infusion therapy during exercise test].
    Rathgeber M; Ockenga T
    Verh Dtsch Ges Inn Med; 1971; 77():983-5. PubMed ID: 5156101
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental prevention of myocardial infarction by bronchial collateral circulation.
    Mobin-Uddin K; Viamonte M; Martinez LO; Gould SE; Jude JR
    JAMA; 1969 Apr; 208(2):301-6. PubMed ID: 5818482
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanical augmentation of coronary circulation in the ischemic heart.
    Chatterjee S; Rosensweij
    Can J Surg; 1969 Oct; 12(4):459-65. PubMed ID: 5352681
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new anti-stenocardiac agent: carbochromen].
    Arcidiacono R; Sanna GP; Fornasero L
    Minerva Cardioangiol; 1971 Dec; 19(12):719-28. PubMed ID: 5129038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.